Ember Therapeutics, Inc. (OTCPK:EMBT) entered into a definitive agreement to acquire the assets of Migralex, Inc. for $0.87 million in stock on March 18, 2016. The purchase price will be paid by the issuance of 1.58 million shares of Ember common stock. The deal is subject to Migralex obtaining and delivering to Ember the consents, waivers and approvals from third parties and governmental entities necessary and required percentage of each class of Migralex's shareholders shall have consented to the agreement and the transactions contemplated hereby, including an acknowledgement that the purchase price represents the fair market value of the purchased assets.

Lee Roth of The Ruth Group acted as public relations advisor for Ember Therapeutics, Inc. Randall Sunberg and Emilio Ragosa of Morgan, Lewis & Bockius LLP acted as legal advisor to Migralex.